Search results
FDA approves second Alzheimer’s drug that can slow onset of disease
The Guardian· 24 hours agoFederal health authorities on Tuesday gave approval to an experimental new drug that has shown to delay the onset of Alzheimer’s disease in trials. Donanemab, manufactured by Eli Lilly, is the ...